Brands: Emtriva · Emtricitabine
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | generic | 3 | SUPPLYING |
| Cipla USA Inc. | generic | 2 | SUPPLYING |
| Gilead Sciences, Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Emtricitabine Oral Solution — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
Emtricitabine Oral Solution — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
Emtricitabine Capsule — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
Emtricitabine Capsule — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
Defective Container; leaking around the cap — Recalling firm: Gilead Sciences, Inc. — United States, Puerto Rico, Fiji.
